On behalf of the Scientific Planning Committee (SPC), I would like to welcome you to a series of newsletters where we will summarize the latest clinical and real-world evidence in the field of dyslipidemia and reflect on the clinical impact of these data on dyslipidemia management.

Every few months we will delve into the recent key articles that may impact clinical practice. We invite you to interact with this newsletter through polling questions, listen/view short clinical perspectives from our SPC, and click on hyperlinks to the articles for in-depth study.

Prof. Farnier (Chair)

Key articles in Newsletter #5: